Pharmaceutical company
Appears in 1 story
Developing dersimelagon as a competing oral EPP drug
People with erythropoietic protoporphyria feel stabbing pain in any strong light; sunlight literally hurts. Disc Medicine's oral pill bitopertin just aced a Phase 3 trial, giving the company a second shot at FDA approval after a rejection in February.
Updated 3 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
